• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物群调节机制:对健康、疾病和治疗干预的影响。

Mechanisms of microbiota modulation: Implications for health, disease, and therapeutic interventions.

机构信息

Department of Publication and Extension, Kampala International University, Kampala, Uganda.

出版信息

Medicine (Baltimore). 2024 May 10;103(19):e38088. doi: 10.1097/MD.0000000000038088.

DOI:10.1097/MD.0000000000038088
PMID:38728472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11081615/
Abstract

Microbiota modulation, the intentional change in the structure and function of the microbial community, is an emerging trajectory that holds the promise to mitigate an infinite number of health issues. The present review illustrates the underlying principles of microbiota modulation and the various applications of this fundamental process to human health, healthcare management, and pharmacologic interventions. Different strategies, directing on dietary interventions, fecal microbiota transplantation, treatment with antibiotics, bacteriophages, microbiome engineering, and modulation of the immune system, are described in detail. This therapeutic implication is reflected in clinical applications to gastrointestinal disorders and immune-mediated diseases for microbiota-modulating agents. In addition to this, the review outlines the challenges of translating researched outcomes into clinical practice to consider safety and provides insights into future research directions of this rapidly developing area.

摘要

微生物组调节,即有意改变微生物群落的结构和功能,是一个新兴的领域,有望缓解无数健康问题。本综述说明了微生物组调节的基本原理,以及这一基本过程在人类健康、医疗保健管理和药物干预方面的各种应用。详细描述了不同的策略,包括饮食干预、粪便微生物群移植、抗生素、噬菌体、微生物组工程和免疫系统调节。这种治疗意义反映在用于调节微生物群的药物在胃肠道疾病和免疫介导性疾病的临床应用中。除此之外,该综述还概述了将研究成果转化为临床实践时需要考虑安全性的挑战,并为这一快速发展领域的未来研究方向提供了思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7e/11081615/b173b96db1db/medi-103-e38088-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7e/11081615/ebba8f735147/medi-103-e38088-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7e/11081615/6cb2960af36b/medi-103-e38088-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7e/11081615/b173b96db1db/medi-103-e38088-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7e/11081615/ebba8f735147/medi-103-e38088-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7e/11081615/6cb2960af36b/medi-103-e38088-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c7e/11081615/b173b96db1db/medi-103-e38088-g003.jpg

相似文献

1
Mechanisms of microbiota modulation: Implications for health, disease, and therapeutic interventions.微生物群调节机制:对健康、疾病和治疗干预的影响。
Medicine (Baltimore). 2024 May 10;103(19):e38088. doi: 10.1097/MD.0000000000038088.
2
Gastrointestinal involvement of autism spectrum disorder: focus on gut microbiota.自闭症谱系障碍的胃肠道受累:关注肠道微生物群。
Expert Rev Gastroenterol Hepatol. 2021 Jun;15(6):599-622. doi: 10.1080/17474124.2021.1869938. Epub 2021 Jan 5.
3
Role of the gastrointestinal microbiota in small animal health and disease.胃肠道微生物群在小动物健康与疾病中的作用。
Vet Rec. 2017 Oct 7;181(14):370. doi: 10.1136/vr.103826. Epub 2017 Sep 15.
4
The impact of modulating the gastrointestinal microbiota in cancer patients.调节癌症患者的胃肠道微生物群的影响。
Best Pract Res Clin Gastroenterol. 2020 Oct-Dec;48-49:101700. doi: 10.1016/j.bpg.2020.101700. Epub 2020 Oct 19.
5
Gut microbiota and eye diseases: A review.肠道微生物群与眼部疾病:综述
Medicine (Baltimore). 2024 Sep 27;103(39):e39866. doi: 10.1097/MD.0000000000039866.
6
Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study.微生物群转移治疗改变肠道生态系统,改善胃肠道和自闭症症状:一项开放标签研究。
Microbiome. 2017 Jan 23;5(1):10. doi: 10.1186/s40168-016-0225-7.
7
Therapeutic potential of microbiome modulation in reproductive cancers.微生物群调节在生殖系统癌症中的治疗潜力
Med Oncol. 2025 Apr 6;42(5):152. doi: 10.1007/s12032-025-02708-2.
8
How to modulate gut microbiota: diet, preprobiotics or antibiotics?如何调节肠道微生物群:饮食、益生元还是抗生素?
Minerva Gastroenterol Dietol. 2017 Dec;63(4):411-419. doi: 10.23736/S1121-421X.17.02382-0. Epub 2017 Feb 17.
9
An Update on Microbial Interventions in Autism Spectrum Disorder with Gastrointestinal Symptoms.自闭症谱系障碍伴胃肠道症状的微生物干预最新进展
Int J Mol Sci. 2024 Dec 5;25(23):13078. doi: 10.3390/ijms252313078.
10
"Gut Microbiota as a Therapeutic Target for Hypertension: Challenges and Insights for Future Clinical Applications" "Gut Microbiota and Hypertension Therapy".“作为高血压治疗靶点的肠道微生物群:未来临床应用的挑战与见解” “肠道微生物群与高血压治疗”
Curr Hypertens Rep. 2025 Apr 22;27(1):14. doi: 10.1007/s11906-025-01331-w.

引用本文的文献

1
Acoustic therapy for allergic rhinitis and chronic rhinosinusitis: modulating microbiome, immunity and well-being.变应性鼻炎和慢性鼻-鼻窦炎的声学疗法:调节微生物群、免疫和健康状况
Front Allergy. 2025 Aug 25;6:1649031. doi: 10.3389/falgy.2025.1649031. eCollection 2025.
2
Obesity as a Chronic Disease: A Narrative Review of Evolving Definitions, Management Strategies, and Cardiometabolic Prioritization.肥胖作为一种慢性疾病:对不断演变的定义、管理策略及心血管代谢优先事项的叙述性综述
Adv Ther. 2025 Sep 5. doi: 10.1007/s12325-025-03352-y.
3
Unlocking the Secrets of Nature: Phytochemicals as Key Players in Longevity and Healthy Aging.

本文引用的文献

1
Early life exposure of infants to benzylpenicillin and gentamicin is associated with a persistent amplification of the gut resistome.婴儿在生命早期接触苄青霉素和庆大霉素会导致肠道耐药组持续扩增。
Microbiome. 2024 Feb 3;12(1):19. doi: 10.1186/s40168-023-01732-6.
2
Gut microbiota alterations in acute myocardial infarction: (diabetic) context is everything.急性心肌梗死中的肠道微生物群改变:(糖尿病)背景至关重要。
Ann Transl Med. 2023 Dec 20;11(12):404. doi: 10.21037/atm-23-1741. Epub 2023 Sep 5.
3
Molecular Insights Into the Role of Gut Microbiota in Antibiotic Therapy Selection and Resistance Mitigation.
揭开自然的秘密:植物化学物质是长寿和健康衰老的关键因素。
Cell Biochem Biophys. 2025 Aug 22. doi: 10.1007/s12013-025-01872-6.
4
Gut-Microbiota-Derived Metabolites and Probiotic Strategies in Colorectal Cancer: Implications for Disease Modulation and Precision Therapy.肠道微生物群衍生代谢产物与结直肠癌的益生菌策略:对疾病调节和精准治疗的影响
Nutrients. 2025 Jul 30;17(15):2501. doi: 10.3390/nu17152501.
5
Unveiling the microbial orchestra: exploring the role of microbiota in cancer development and treatment.揭开微生物的“管弦乐队”之谜:探索微生物群在癌症发生发展及治疗中的作用。
Discov Oncol. 2025 Apr 30;16(1):646. doi: 10.1007/s12672-025-02352-2.
6
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention.肠道微生物短链脂肪酸对结直肠癌发生发展及预防的影响
Gut Microbes. 2025 Dec;17(1):2483780. doi: 10.1080/19490976.2025.2483780. Epub 2025 Apr 6.
7
Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders.自身免疫性疾病中与T细胞和B细胞相关的新机制及生物标志物
Clin Rev Allergy Immunol. 2025 Feb 11;68(1):14. doi: 10.1007/s12016-025-09022-9.
8
Emerging Role of Gut Microbiota in Breast Cancer Development and Its Implications in Treatment.肠道微生物群在乳腺癌发展中的新作用及其对治疗的影响
Metabolites. 2024 Dec 5;14(12):683. doi: 10.3390/metabo14120683.
9
Immune mechanisms and shared immune targets in neurodegenerative diseases.神经退行性疾病中的免疫机制和共同免疫靶点
Nat Rev Neurol. 2025 Feb;21(2):67-85. doi: 10.1038/s41582-024-01046-7. Epub 2024 Dec 16.
10
Fecal microbiome composition in neonates with or without urinary tract infection.有或无尿路感染的新生儿的粪便微生物群组成
Pediatr Nephrol. 2025 Apr;40(4):1015-1021. doi: 10.1007/s00467-024-06612-1. Epub 2024 Nov 28.
肠道微生物群在抗生素治疗选择和耐药性缓解中作用的分子见解
Cureus. 2023 Dec 11;15(12):e50318. doi: 10.7759/cureus.50318. eCollection 2023 Dec.
4
Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey.关于微生物群调节、抗生素、益生菌和粪便微生物移植用于炎症性肠病及其他胃肠道疾病的疗效、安全性和相关问题:一项国际调查的结果
Microorganisms. 2023 Nov 19;11(11):2806. doi: 10.3390/microorganisms11112806.
5
A systematic review on diagnosis and treatment of gastrointestinal diseases by magnetically controlled capsule endoscopy and artificial intelligence.磁控胶囊内镜与人工智能在胃肠道疾病诊断和治疗中的系统评价
Therap Adv Gastroenterol. 2023 Oct 27;16:17562848231206991. doi: 10.1177/17562848231206991. eCollection 2023.
6
Gut microbiota and autism spectrum disorders: where do we stand?肠道微生物群与自闭症谱系障碍:我们目前的进展如何?
Gut Pathog. 2023 Oct 25;15(1):50. doi: 10.1186/s13099-023-00575-8.
7
Global trends in research related to the links between microbiota and antibiotics: a visualization study.全球微生物群与抗生素关联研究趋势:可视化研究。
Sci Rep. 2023 Apr 27;13(1):6890. doi: 10.1038/s41598-023-34187-8.
8
Type 2 Diabetes and the Microbiome.2型糖尿病与微生物群
J Endocr Soc. 2022 Nov 30;7(2):bvac184. doi: 10.1210/jendso/bvac184. eCollection 2022 Dec 15.
9
Microbiota Modulation in Patients with Metabolic Syndrome.代谢综合征患者的微生物组调节。
Nutrients. 2022 Oct 25;14(21):4490. doi: 10.3390/nu14214490.
10
Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases.肠道微生物群调节作为心血管代谢疾病的一种新型治疗策略
Foods. 2022 Aug 25;11(17):2575. doi: 10.3390/foods11172575.